HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takaaki Abe Selected Research

Tryptophanase

1/2022(+)-Sesamin, a sesame lignan, is a potent inhibitor of gut bacterial tryptophan indole-lyase that is a key enzyme in chronic kidney disease pathogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takaaki Abe Research Topics

Disease

14Chronic Renal Insufficiency
01/2022 - 09/2011
11Renal Insufficiency (Renal Failure)
12/2021 - 12/2009
10Hypertension (High Blood Pressure)
01/2022 - 09/2003
9Inflammation (Inflammations)
03/2022 - 12/2009
9Neoplasms (Cancer)
12/2021 - 12/2003
8Mitochondrial Diseases (Mitochondrial Disease)
03/2022 - 01/2015
7Fibrosis (Cirrhosis)
12/2021 - 01/2012
6Ischemia
01/2019 - 01/2013
5Proteinuria
01/2021 - 09/2003
5Renal Artery Obstruction (Renal Artery Stenosis)
11/2010 - 03/2005
4Breast Neoplasms (Breast Cancer)
12/2021 - 10/2007
4Adenoma (Adenomas)
11/2007 - 07/2006
3Kidney Diseases (Kidney Disease)
03/2022 - 04/2011
3Reperfusion Injury
01/2019 - 01/2016
3Carcinoma (Carcinomatosis)
09/2008 - 07/2007
3Heart Failure
03/2004 - 10/2003
2Infarction (Infarctions)
01/2022 - 01/2020
2Dysbiosis
12/2021 - 08/2015
2Diabetic Nephropathies (Diabetic Nephropathy)
12/2021 - 01/2019
2Type 2 Diabetes Mellitus (MODY)
12/2021 - 01/2013
2COVID-19
01/2021 - 01/2020
2Gout
01/2020 - 01/2020
2Hyperuricemia
01/2020 - 01/2020
2Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 09/2011
2Stroke (Strokes)
01/2020 - 01/2019
2Colonic Neoplasms (Colon Cancer)
01/2019 - 01/2008
2Gitelman Syndrome
11/2017 - 02/2015
2Fibromuscular Dysplasia
10/2017 - 10/2007
2Pathologic Constriction (Stenosis)
10/2017 - 10/2007
2Renovascular Hypertension (Goldblatt Syndrome)
10/2017 - 03/2005
2Chronic Kidney Failure (Chronic Renal Failure)
09/2017 - 09/2003
2Body Weight (Weight, Body)
09/2017 - 01/2013
2Acute Kidney Injury (Acute Renal Failure)
01/2017 - 01/2017
2Hepatocellular Carcinoma (Hepatoma)
01/2015 - 09/2008
2Transfusion Reaction
08/2014 - 11/2011
2Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I)
01/2013 - 01/2012
2Insulin Resistance
01/2013 - 01/2010
2Cardiomegaly (Heart Hypertrophy)
09/2011 - 12/2009
2Colorectal Neoplasms (Colorectal Cancer)
09/2008 - 01/2008
2Hypokalemia
01/2008 - 06/2007
1Peritoneal Fibrosis
03/2022

Drug/Important Bio-Agent (IBA)

11Uremic ToxinsIBA
02/2021 - 12/2009
10Pharmaceutical PreparationsIBA
01/2021 - 08/2005
7ReninIBA
01/2021 - 10/2003
7Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2007
6Transfer RNA (tRNA)IBA
01/2022 - 10/2014
6AdenineFDA LinkGeneric
12/2021 - 08/2015
6Biomarkers (Surrogate Marker)IBA
11/2019 - 09/2011
6Messenger RNA (mRNA)IBA
01/2017 - 03/2002
6AldosteroneIBA
01/2008 - 09/2003
5Adenosine Triphosphate (ATP)IBA
06/2017 - 03/2014
44- (2,4- difluorophenyl)- 2- (1H- indol- 3- yl)- 4- oxobutanoic acidIBA
03/2022 - 01/2015
4EnzymesIBA
01/2022 - 09/2015
4Sulfates (Sulfates, Inorganic)IBA
12/2021 - 01/2018
4CreatinineIBA
01/2021 - 10/2003
3indoleacetic acid (indole acetic acid)IBA
03/2022 - 01/2015
3Antihypertensive Agents (Antihypertensives)IBA
01/2022 - 06/2007
3SaltsIBA
01/2022 - 03/2014
3Glucose (Dextrose)FDA LinkGeneric
12/2021 - 01/2013
3Amino AcidsFDA Link
12/2021 - 01/2017
3Indicators and Reagents (Reagents)IBA
12/2021 - 03/2009
3Uric Acid (Urate)IBA
01/2020 - 06/2010
3AST 120IBA
01/2020 - 11/2012
3indoleIBA
01/2019 - 01/2016
3Mitochondrial DNA (mtDNA)IBA
01/2018 - 01/2015
3AnionsIBA
03/2014 - 09/2011
3CationsIBA
03/2014 - 07/2007
3Bile Acids and Salts (Bile Acids)IBA
09/2008 - 10/2007
3Doxorubicin (Adriamycin)FDA LinkGeneric
07/2007 - 08/2005
2Amino Acid Transport Systems (Amino Acid Transporter)IBA
12/2021 - 08/2021
2Tyrosine (L-Tyrosine)FDA Link
12/2021 - 01/2019
2Phenol (Carbolic Acid)FDA Link
12/2021 - 01/2019
2Phenobarbital (Luminal)FDA Link
12/2021 - 04/2011
2Hormones (Hormone)IBA
08/2021 - 10/2007
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2020 - 01/2019
2Volatile Fatty AcidsIBA
12/2019 - 01/2017
2AntibodiesIBA
01/2019 - 08/2014
21-methyladenosineIBA
01/2019 - 01/2019
2IndicanIBA
10/2018 - 11/2016
2N,N-dimethylarginine (asymmetric dimethylarginine)IBA
09/2017 - 12/2009
2Phosphotransferases (Kinase)IBA
01/2017 - 01/2008
2AntioxidantsIBA
01/2016 - 01/2015
2Transcription Factors (Transcription Factor)IBA
12/2015 - 09/2008
2Biological ProductsIBA
09/2014 - 10/2007
2Immunoglobulin E (IgE)IBA
08/2014 - 11/2011
2Organic Anion TransportersIBA
03/2014 - 12/2009
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2013 - 01/2012
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2011 - 12/2004
2Pravastatin (Pravachol)FDA LinkGeneric
01/2010 - 12/2009
2Solute Carrier Organic Anion Transporter Family Member 1B3IBA
01/2008 - 10/2007
2Losartan (Cozaar)FDA LinkGeneric
10/2007 - 06/2007
1chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric
03/2022
1LignansIBA
01/2022
1TryptophanaseIBA
01/2022
1sesaminIBA
01/2022
1PrebioticsIBA
01/2022

Therapy/Procedure

13Therapeutics
08/2021 - 10/2003
2Drug Therapy (Chemotherapy)
12/2021 - 02/2008
1Intraperitoneal Injections
03/2022
1Peritoneal Dialysis
03/2022